Showing results (281-290 of 421) with videos related to

Sort By:
Pageof 43
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 16, 2014
Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention TrialAlan R Kristal, Cathee Till, Xiaoling Song, et al.
European Urology Oncology|November 9, 2024
Correlation of Body Mass Index with Overall Survival Among Patients with Metastatic Hormone-sensitive Prostate Cancer: Analysis of Patient-level Data from SWOG-1216Umang Swami, Yeonjung Jo, Arshit Narang, et al.
Urology|March 6, 2012
Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: update on Southwest Oncology Group Study 9109Ryan K Berglund, Catherine M Tangen, Isaac J Powell, et al.
The Prostate|January 3, 2013
Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancerChun-Liang Chen, Devalingam Mahalingam, Pawel Osmulski, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 15, 2013
Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: results from the prostate cancer prevention trialMarian L Neuhouser, Elizabeth A Platz, Cathee Till, et al.
Urology|February 5, 2008
The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancerElisabeth I Heath, Michael W Kattan, Isaac J Powell, et al.
The Journal of Urology|November 5, 2016
Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance StudyLiam C Macleod, William J Ellis, Lisa F Newcomb, et al.
Urology|May 15, 2014
Androgen receptor CAG repeat length and TMPRSS2:ETS prostate cancer risk: results From the Prostate Cancer Prevention TrialWilliam D Figg, Cindy H Chau, Douglas K Price, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 30, 2021
Phase I Trial of Encapsulated Rapamycin in Patients with Prostate Cancer Under Active Surveillance to Prevent ProgressionPhillip M Kemp Bohan, Robert C Chick, Anne E O'Shea, et al.
Cancer Research|May 28, 2021
Contacts with Macrophages Promote an Aggressive Nanomechanical Phenotype of Circulating Tumor Cells in Prostate CancerPawel A Osmulski, Alessandra Cunsolo, Meizhen Chen, et al.
Pageof 43